Comparison of Plasma Rifampicin Concentrations at 0, 2, 4 and 6 Hours in Pulmonary Tuberculosis Patients With and Without Diabetes Mellitus: A Cross-Sectional Study
International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.70 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Ved Prakash Agrawal und 1 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Tuberculosis (TB) continues to be a major global health burden, especially in developing countries. Diabetes mellitus (DM), a rapidly growing non-communicable disease, adversely affects TB outcomes and may alter the pharmacokinetics of anti-tubercular drugs like rifampicin. Subtherapeutic drug levels may contribute to treatment failure and drug resistance.
Aim
To compare plasma rifampicin concentrations at 0, 2, 4, and 6 hours in pulmonary tuberculosis patients with and without diabetes mellitus. Materials and Methods: This cross-sectional observational study was conducted in the Department of Pharmacology, JLN Medical College, Ajmer, from October 2020 to August 2021. Sixty newly diagnosed pulmonary TB patients were enrolled, including 30 with DM and 30 without DM, all receiving anti-tubercular therapy as per National Tuberculosis Elimination Programme guidelines. Blood samples were collected at predose (0 hour) and 2, 4, and 6 hours post-dose after achieving steady state. Plasma rifampicin levels were estimated using validated reverse-phase high-performance liquid chromatography. Statistical analysis was performed using Student’s t-test and Chi-square test.
Results
Mean rifampicin concentrations at 2, 4, and 6 hours were significantly lower in diabetic patients compared to non-diabetics (p
Zitieren
APA
Agrawal, V. P., & Mathur, S. K. (2026). Comparison of Plasma Rifampicin Concentrations at 0, 2, 4 and 6 Hours in Pulmonary Tuberculosis Patients With and Without Diabetes Mellitus: A Cross-Sectional Study. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.70
Vancouver
Agrawal VP, Mathur SK. Comparison of Plasma Rifampicin Concentrations at 0, 2, 4 and 6 Hours in Pulmonary Tuberculosis Patients With and Without Diabetes Mellitus: A Cross-Sectional Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.70
BibTeX
@article{Agrawal2026,
author = {Agrawal, Ved Prakash and Mathur, Sunil Kumar},
title = {Comparison of Plasma Rifampicin Concentrations at 0, 2, 4 and 6 Hours in Pulmonary Tuberculosis Patients With and Without Diabetes Mellitus: A Cross-Sectional Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.70}
}
EUVIMED